Sarah Beth Newey, DPM | |
3451 Granger Rd, Akron, OH 44333-1532 | |
(330) 623-6680 | |
Not Available |
Full Name | Sarah Beth Newey |
---|---|
Gender | Female |
Speciality | Podiatry |
Experience | 14 Years |
Location | 3451 Granger Rd, Akron, Ohio |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1124330949 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
213ES0131X | Podiatrist - Foot Surgery | 36.003858 (Ohio) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Summa Health System | Akron, OH | Hospital |
Provider Name | Wound Care Consultants Llc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1831495373 PECOS PAC ID: 2567646359 Enrollment ID: O20110401000409 |
News Archive
Researchers at University of California San Diego School of Medicine have shown that ozanimod (RPC1063), a novel drug molecule, is moderately effective in the treatment of ulcerative colitis. Results of the Phase II clinical trial will appear in the May 5 issue of the New England Journal of Medicine.
Research led by Paola Leone, PhD, of the University of Medicine and Dentistry of New Jersey-School of Osteopathic Medicine (UMDNJ-SOM), demonstrates the long term safety and benefit of a virus-based gene therapy that has been applied for the first time in a clinical setting.
Use of gemcitabine, a drug that can be effective in treating advanced and resected pancreatic cancer, did not result in improved overall survival after pancreatic cancer resection (surgical removal) compared to patients who received fluorouracil and folinic acid, another treatment regimen that has shown effectiveness, according to a study in the September 8 issue of JAMA.
Researchers and clinicians at UT Southwestern Medical Center are among a small, select group at U.S. universities to receive inaugural funding from the American Heart Association (AHA) for work that takes aim at heart disease and stroke.
› Verified 8 days ago
Provider Name | Newey Foot Clinic Llc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1255805446 PECOS PAC ID: 3274876834 Enrollment ID: O20190604001386 |
News Archive
Researchers at University of California San Diego School of Medicine have shown that ozanimod (RPC1063), a novel drug molecule, is moderately effective in the treatment of ulcerative colitis. Results of the Phase II clinical trial will appear in the May 5 issue of the New England Journal of Medicine.
Research led by Paola Leone, PhD, of the University of Medicine and Dentistry of New Jersey-School of Osteopathic Medicine (UMDNJ-SOM), demonstrates the long term safety and benefit of a virus-based gene therapy that has been applied for the first time in a clinical setting.
Use of gemcitabine, a drug that can be effective in treating advanced and resected pancreatic cancer, did not result in improved overall survival after pancreatic cancer resection (surgical removal) compared to patients who received fluorouracil and folinic acid, another treatment regimen that has shown effectiveness, according to a study in the September 8 issue of JAMA.
Researchers and clinicians at UT Southwestern Medical Center are among a small, select group at U.S. universities to receive inaugural funding from the American Heart Association (AHA) for work that takes aim at heart disease and stroke.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Sarah Beth Newey, DPM 11100 Euclid Ave, University Hospitals Case Medical Center, Cleveland, OH 44106 Ph: () - | Sarah Beth Newey, DPM 3451 Granger Rd, Akron, OH 44333-1532 Ph: (330) 623-6680 |
News Archive
Researchers at University of California San Diego School of Medicine have shown that ozanimod (RPC1063), a novel drug molecule, is moderately effective in the treatment of ulcerative colitis. Results of the Phase II clinical trial will appear in the May 5 issue of the New England Journal of Medicine.
Research led by Paola Leone, PhD, of the University of Medicine and Dentistry of New Jersey-School of Osteopathic Medicine (UMDNJ-SOM), demonstrates the long term safety and benefit of a virus-based gene therapy that has been applied for the first time in a clinical setting.
Use of gemcitabine, a drug that can be effective in treating advanced and resected pancreatic cancer, did not result in improved overall survival after pancreatic cancer resection (surgical removal) compared to patients who received fluorouracil and folinic acid, another treatment regimen that has shown effectiveness, according to a study in the September 8 issue of JAMA.
Researchers and clinicians at UT Southwestern Medical Center are among a small, select group at U.S. universities to receive inaugural funding from the American Heart Association (AHA) for work that takes aim at heart disease and stroke.
› Verified 8 days ago
Foot Health And Wellness, Llc Podiatrist Medicare: Medicare Enrolled Practice Location: 2717 S Arlington Rd, Suite G, Akron, OH 44312 Phone: 330-644-4303 | |
Akron Ambulatory Foot Surgeons Inc Podiatrist Medicare: Medicare Enrolled Practice Location: 335 E Waterloo Rd, Akron, OH 44319 Phone: 330-724-8689 Fax: 330-724-5470 | |
Tracey R Burns, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 575 White Pond Dr, Suite A, Akron, OH 44320 Phone: 330-835-1629 Fax: 330-835-3863 | |
Premier Foot & Ankle Care Llc Podiatrist Medicare: Medicare Enrolled Practice Location: 3593 S Arlington Rd Ste C, Akron, OH 44312 Phone: 330-899-1051 Fax: 330-899-1057 | |
Reed B Graham, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 696 Canton Rd Ste 1, Akron, OH 44312 Phone: 330-535-8202 Fax: 330-535-3065 | |
Laser Foot Care Center Inc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 2495 Olentangy Dr, Akron, OH 44333 Phone: 330-603-8898 |